Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine after Electrocardioversion for Atrial Fibrillation
NCT05890664Phase 3Recruiting
- Sponsor
- University Hospital Basel
- Start
- Apr 2024
- Primary completion
- Mar 2027
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of colchicine in Atrial fibrillation (AFib), sponsored by University Hospital Basel. Started Apr 2024; status: recruiting.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05890664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05890664.